Skip to main content
Clinical Trials/KCT0004270
KCT0004270
Not yet recruiting
未知

International Multi-Center Observational Study of Lung-protective Ventilation in Asian ICUs

Asan Medical Center0 sites1,000 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of th respiratory system
Sponsor
Asan Medical Center
Enrollment
1000
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age above 18
  • 2\. Patients who are admitted to intensive care unit and are on invasive mechanical ventilation.

Exclusion Criteria

  • Age below 18

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study international multi center study to find out the current practices using in patient admitted in intensive care unit while giving breathing with the help of artificial breathing machine in intensive care units across all Asia.Health Condition 1: J969- Respiratory failure, unspecified
CTRI/2019/07/020215Tata Memorial Hospital
Recruiting
Not Applicable
International multicenter observational study to determine the diagnostic sensitivity of plasma metanephrines and urinary catecholamines and metabolites compared to standard evaluation procedures in children with high risk neuroblastoma
NL-OMON51513Centre Hospitalier Universitaire Vaudois-CHUV30
Completed
Not Applicable
YAK.1.C.A: The colonisation of the intestine in childre
ISRCTN66704989Yakult Honsha European Research Center111
Completed
Not Applicable
An International Multi-Center Cohort Study of the Incidence of Anesthesia Awareness Following Laryngoscopy and IntubatioanesthesieIntraoperative AwarenessIntraoperative Complications
NL-OMON42193anesthesiologie- onderzoeksbureau25
Active, not recruiting
Not Applicable
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2009-013884-21-DEEnceladus Pharmaceuticals BV90